×
2022/04/08 · Interpretation: Combining androgen deprivation therapy, docetaxel, and abiraterone in de novo metastatic castration-sensitive prostate cancer ...
Karim Fizazi concluded his report of the PEACE-1 trial data by stating that the addition of abiraterone to ADT and docetaxel significantly improved radiographic ...
関連する質問
2022/04/21 · The investigators concluded: “Combining androgen deprivation therapy, docetaxel, and abiraterone in de novo metastatic castration-sensitive ...
2023/06/06 · ASCO 2023 results from the phase III PEACE-1 trial, prostate irradiation in men with de novo low-volume metastatic castrate-sensitive ...
A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer (PEACE1). The safety and scientific validity of this study is the responsibility ...
2018/12/06 · UNICANCER A Phase III of ADT + Docetaxel +/− Local RT +/− Abiraterone Acetate in Metastatic Hormone-Naïve Prostate Cancer (PEACE1) [ ...
2022/06/20 · In our exclusive interview, Dr Wise discussed practice-changing findings from the phase 3 ARASENS (NCT02799602) and PEACE1 (NCT01957436) trials.
Episode 110: PEACE1 - Triplet therapy in prostate cancer The Uromigos ... Karim Fizazi describes the results of this randomised, potentially practice-changing ...